Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 482.76 M534.49 M521.59 M511.03 M706.23 M 2.27 B Research & development ————— — Operating income 297.12 M-230.48 M-129.25 M-333.75 M704.09 M 10.61 M Non-Operating Income, Total -2.92 M2.79 M-3.18 M-20.03 M71 K -20.35 M Interest expense, net of interest capitalized 5.99 M5.85 M6.86 M-1.1 M5.38 M 16.99 M Non-Operating Income, excl. Interest Expenses -2.92 M2.79 M-3.18 M-20.03 M71 K -20.35 M Unusual income/expense ————— — Pretax income 288.21 M-233.54 M-139.29 M-352.68 M698.77 M -26.73 M Equity in earnings ————— — Taxes 12.71 M-5.04 M-1.81 M-247 K19.75 M 12.65 M Non-controlling/minority interest 235 K-130 K-34 K177 K27 K 40 K After tax other income/expense ————— — Net income before discontinued operations 275.27 M-228.36 M-137.45 M-352.61 M679 M -39.43 M Discontinued operations ————— — Net income 275.27 M-228.36 M-137.45 M-352.61 M679 M -39.43 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 275.27 M-228.36 M-137.45 M-358.1 M682.72 M -41.19 M Basic earnings per share (Basic EPS) 1.1-0.89-0.53-1.372.28 -0.51 Diluted earnings per share (Diluted EPS) 0.92-0.89-0.53-1.192.07 -0.54 Average basic shares outstanding 251.28 M255.53 M259.27 M262.39 M298.18 M — Diluted shares outstanding 305.94 M255.53 M259.27 M262.39 M329.75 M — EBITDA 301.93 M-201.24 M-114.56 M-317.93 M718.18 M 84.44 M EBIT 312.5 M-208.21 M-121.87 M-325.81 M711.16 M 55.26 M Cost of revenue 2.25 B2.54 B2.59 B2.62 B3.23 B 10.97 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 6.73 M6.97 M7.31 M7.88 M7.02 M 29.18 M